Zimmer Biomet Holdings (ZBH) Misses Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS Guidance Below Consensus; FY17 Revenue Outlook Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/4/2026

1. PANW
2. SPY
3. ULTA
4. GTLB
5. USO
6. CRWD
7. GOOGL
8. MDT
9. AVGO
10. VRTS

Go back to Zimmer Biomet Holdings (ZBH) Misses Q3 EPS by 4c, Miss on Revenues; Lowers FY17 EPS Guidance Below Consensus; FY17 Revenue Outlook Below Consensus

Piper Jaffray Downgrades Zimmer Biomet (ZBH) to Neutral

November 2, 2017 4:54 AM EDT

Piper Jaffray downgraded Zimmer Biomet (NYSE: ZBH) from Overweight to Neutral with a price target of $110.00 (from $135.00).

Analyst Matt O'Brien cites a plethora of uncertainties pushes him to the sidelines and comments that altering the fundamental growth of the business will... More